FDA NDC Directory · JSON-LD · Markdown
NDC 11534-197 · HUMAN PRESCRIPTION DRUG · CAPSULE
| Labeler / Manufacturer | Sunrise Pharmaceutical, Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA211421 |
| Dosage form / route | CAPSULE · ORAL |
| Active ingredients | CHLORDIAZEPOXIDE HYDROCHLORIDE (5 mg/1) CLIDINIUM BROMIDE (2.5 mg/1) |
| Marketing started | 20200709 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).